IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Nidan Laboratories and Healthcare IPO is a Fixed Price listing on NSE EMERGE exchange. The company is based in Palagar and caters to Healthcare - Hospitals And Clinic sector. First Overseas Capital is the merchant banker of Nidan Laboratories and Healthcare IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 23rd October 2021.
Nidan Laboratories and Healthcare IPO posted revenues of ₹ 31.40 crores and PAT of ₹ 4.36 crores in FY22 on annualised basis.
Revenue:
₹ 31.32 Cr.
EBITDA Margin:
40.61
% 
Net Worth: ₹ 14.42 Cr.
Market Capitalisation:
₹ 173.57 Cr.
P/E:
39.81 times
P/BV: 2.69 times
EV/EBITDA: 15.88 times
Financial results of Nidan Laboratories and Healthcare IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
| Financials | Jun-21 | FY21 | FY20 | FY19 | |
|---|---|---|---|---|---|
|
Balance Sheet
|
|||||
| Assets | 32.97 | 31.52 | 24.33 | 19.00 | |
| Net Worth | 14.42 | 13.33 | 11.03 | 10.31 | |
| Total Debt | 37.09 | 36.50 | 34.35 | 32.17 | |
|
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
7.83
31.32 |
20.79 | 22.18 | 20.61 | |
EBITDA
EBITDA on annualised basis |
3.18
12.72 |
9.95 | 7.65 | 8.21 | |
PAT
PAT on annualised basis |
1.09
4.36 |
2.30 | 0.71 | 0.22 | |
Nidan Laboratories and Healthcare IPO PAT Margin is 13.92 % , ROCE (Return on Capital Employed) is [●] % as per latest financial. The below table shows Nidan Laboratories and Healthcare IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
| Particulars | Jun-21 | FY21 | FY20 | FY19 |
|---|---|---|---|---|
| EBITDA Margin (%) | 40.61 | 47.86 | 34.49 | 39.84 |
| PAT Margin (%) | 13.92 | 11.06 | 3.20 | 1.07 |
| EPS (₹) | [●] | 0.17 | 0.06 | 0.02 |
| ROE (%) | 7.56 | 17.25 | 6.44 | 2.13 |
| ROCE (%) | [●] | [●] | [●] | [●] |
| ROA (%) | 3.31 | 7.30 | 2.92 | 1.16 |
| Debt to Equity | 2.57 | 2.74 | 3.11 | 3.12 |
The market Capitalisation of Nidan Laboratories and Healthcare IPO is ₹ 173.57 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Nidan Laboratories and Healthcare IPO prospectus highlights an Return on Equity (ROE) of 15 %, Return on Assets (ROA) of 12 %, and an EBITDA Margin of 18 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Nidan Laboratories and Healthcare IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Nidan Laboratories and Healthcare IPO is ₹ 173.57 Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Nidan Laboratories and Healthcare IPO has a Price-to-Earnings (PE) ratio of 39.81 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Nidan Laboratories and Healthcare IPO reported revenue of ₹ 31.40 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Nidan Laboratories and Healthcare IPO provide insights into sales growth, market demand, and business scalability.
Nidan Laboratories and Healthcare recorded an EBITDA of ₹ 12.72 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Nidan Laboratories and Healthcare Profit After Tax (PAT) is ₹ 4.36 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 31.32 Cr.
EBITDA Margin:
40.61
%
Net Worth: ₹ 14.42 Cr.
Market Capitalisation:
₹ 173.57 Cr.
P/E:
39.81 times
P/BV: 2.69 times
EV/EBITDA: 15.88 times
Nidan Laboratories and Healthcare operates in Healthcare - Hospitals And Clinic and Healthcare Service Provider. The Issue is listed on NSE EMERGE in Nov, 2021. Nidan Laboratories and Healthcare IPO size was 50.00 with Issue price of 125.00 .
Merchant Banker(s) of Nidan Laboratories and Healthcare IPO: First Overseas Capital Limited
Nidan Laboratories and Healthcare IPO subscription was 1.80 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Nidan Laboratories and Healthcare IPO listed at a listing price of 117.75 against the offer price of 125.00.
The current market price of Nidan Laboratories and Healthcare is 20.00.
Why Us?
